HNB
PTCT icon

Huntington National Bank’s PTC Therapeutics PTCT Stock Holding History

Huntington National Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-410
Closed -$25K – 1787
2020
Q4 		$25K Hold
410
– – ﹤0.01% 1047
2020
Q3 		$19K Buy
+410
New +$20.2K ﹤0.01% 1069
2016
Q1 		– Sell
-262
Closed -$8K – 1806
2015
Q4 		$8K Sell
262
-43
-14% -$1.27K ﹤0.01% 1382
2015
Q3 		$8K Buy
+305
New +$13K ﹤0.01% 1449

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Huntington National Bank's PTCT Position: Q1 2021 in Review

Huntington National Bank sold out of PTC Therapeutics (PTCT) in Q1 2021, closing a stake of 410 shares — an estimated $25K sold.

Huntington National Bank first reported a position in PTCT in Q3 2015 and held it in 4 quarters. The position peaked at $25K in Q4 2020. 208 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

  • Huntington National Bank reported no remaining PTC Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Huntington National Bank sold 410 PTC Therapeutics shares in Q1 2021, an estimated $25K.
  • Huntington National Bank first reported a position in PTC Therapeutics in Q3 2015 and held it in 4 quarters.
  • Huntington National Bank's PTC Therapeutics position peaked at $25K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on Huntington National Bank's 13F filing for Q1 2021, filed 12 Apr 2021.